Penerangan produk
Indikasi
Indicated for the treatment of cholestatic pruritus in patients 3 months of age and older with progressive familial intrahepatic cholestasis (PFIC), and in patients 12 months of age and older with Alagille syndrome (ALGS).
Mekanisme Tindakan
IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Farmakologi
12.1 Mekanisme Tindakan IBAT PFIC ALGS PFIC PFIC ALGS , IBAT , , [ 12.2 ]
Dos dan Cara Penggunaan
2.1 3 PFIC BYLVAY 40 mcg/kg, , 1 3 , 40 mcg/kg , 120 mcg/kg, 6 mg BYLVAY 19.5 kg BYLVAY 19.5 kg
Langkah Berjaga-jaga
5.1 BYLVAY (DILI) PFIC ALGS , 6 DILI ,2 ALGS PFIC , 6 8 , , BYLVAY ,
Kontraindikasi
IBAT BYLVAY , [ Langkah Berjaga-jaga 5.1 ]
Interaksi Ubat
7.1 , BYLVAY 4 4 [ Dos dan Cara Penggunaan (2.3)] , BYLVAY
Kesan Sampingan
[ Langkah Berjaga-jaga(5.1)] [ Langkah Berjaga-jaga(5.2)] [ Langkah Berjaga-jaga(5.3)] 6.1 , , PFIC 1 24 , BYLVAY 40 mcg/kg 120 mcg/kg [ (14.1)]
